Influenza vaccine information for health professionals

On this page:

Back to:

Immunization is the most effective strategy to reduce the impact of influenza in our community, as it can prevent or attenuate influenza illness, and reduce mortality, hospitalization, and complications, such as pneumonia. Ottawa Public Health will support your efforts to increase vaccine coverage in your facility by providing information and resources, and by having public health staff available for consultation.

The annual National Advisory Committee on Immunization (NACI) statement for 2015-2016 is posted on the Public Health Agency of Canada web site. NACI (2015) concludes that “egg allergic individuals may be vaccinated against influenza using TIV, without prior influenza vaccine skin test and with the full dose, irrespective of a past severe reaction to egg. 

What's new this year?

This year, there are now more options to protect children and youth.

For children two years to 17 years, a nasal spray influenza vaccine: FluMist Quadrivalent® is now available that protects against four flu virus strains as opposed to three: B/Brisbane/60/2008-like virus strain along with A/California/7/2009(H1N1) pdm09-like virus,A/ Switzerland/9715293/2013 (H3N2)-like virus, B/Phuket/3073/2013-like virus. FluMist Quadrivalent® is a live attenuated influenza vaccine (LAIV) administered through the intranasal route and directly stimulates local mucosal immunity as well as systemic and is recommended by the Canadian National Advisory Committee on Immunization (NACI) as a first choice.

For children six months to 17 years, a new quadrivalent injection is available that also protects against four different flu virus strains: Fluzone Quadrivalent® and FluLaval Tetra® (subject to availability). This injection contains an additional B strain: B/Brisbane/60/2008-like virus strain along with A/California/7/2009(H1N1) pdm09-like virus,A/ Switzerland/9715293/2013 (H3N2)-like virus, B/Phuket/3073/2013-like virus. 

[ Top ]

Publicly Funded Influenza Vaccines 2015/16

 

Agriflu®/
Fluviral®

Influvac®

Fluad®

FluLaval Tetra® / Fluzone Quadrivalent®

Flumist® Quadrivalent

Influenza Vaccine Formulation

Trivalent inactivated vaccine (TIV)

Trivalent inactivated vaccine (TIV)

Trivalent inactivated vaccine (adjuvanted) (TIV-adjuvanted)

Quadrivalent inactivated vaccine (QIV)

Quadrivalent live attenuated vaccine (Q-LAIV)

Dosage/ Route of Administration

0.5mL / IM Injection

0.5mL / IM  Injection

0.5mL / IM

Injection

0.5mL / IM

Injection

0.2mL (0.1mL in each nostril) Nasal Spray

Eligibility
(see "Vaccines for Specific Age Groups" below)

6 months and older

18 years and older

65 years and older who reside in long-term care homes

6 months through 17 years

2 through 17 years; preferred vaccine for 2 through 5 years

Potential Allergens

Agriflu: Egg protein^
Kanamycin
Neomycin Thimerosal

Fluviral:
Egg protein^
Thimerosal

Egg protein^
Chicken protein
Gentamicin

Egg protein^
Chicken protein
Kanamycin
Neomycin

FluLaval:
Egg protein^
Thimerosal

Fluzone:
Egg protein^
Thimerosal

Arginine
Egg protein
Gelatin
Gentamicin

 ^ Egg allergy is not a contraindication to receiving inactivated influenza vaccines (see National Advisory Committee on Immunization Influenza Statement).

Top ]

Which vaccine to choose:

Age Group

Recommended Vaccine

Alternative Vaccine

6 through 23 months

QIV

TIV  

(if requested or if QIV is not available)

2 through 5 years

Q-LAIV

QIV

(if requested or if Q-LAIV is not available)
TIV

 (if requested or if QIV is not available)

6 through 17 years

QIV or Q-LAIV

TIV (if requested or if QIV / Q-LAIV is not available)

18 years and older

TIV

None

65 years and older who reside in long-term care homes

TIV-adjuvanted

TIV (if requested or if TIV-adjuvanted is not available)

Top ]

Vaccine ordering and pick up

Vaccine Distribution Room hours are Monday to Friday, 8 am to 4 pm. NOTE: November 11 is a statutory holiday and the Vaccine Distribution Room will be closed.

  1. Use the Seasonal Influenza Vaccine Order Form from Ottawa Public Health, not the MOHLTC form
  2. Place your order in doses. Orders will be filled in the order they are received, with priority to high-risk groups. Please allow 7-10 business days for your order to be processed.
  3. Always reserve a small quantity of vaccine for persons age 65 and over, and persons under 65 with medical conditions that put them at high risk for influenza-related complications
  4. Your facility will be called when your order is ready. Arrange to pick up your order within 48 hours of notification at the Ottawa Public Health Vaccine Program, 100 Constellation Drive.
  5. Bring your own cooler and ice pack
  6. Vaccine that is not used by your facility cannot be redistributed. To reduce vaccine wastage, only order the quantity that you are sure to use. You can order more vaccine as needed.

Also available for downloading are:

  • Influenza Vaccine Consent Form - 
  • Influenza Vaccine Consent Form (Fluad®) - 
  • Adult: 18 years and over - Influenza Vaccine Consent Form - 
  • 6 months to 17 years - Influenza Vaccine Consent Form -
  • Seasonal Influenza Immunization Record -

[top]

Vaccine strains

During the 2015/2016 season, seven different influenza vaccine products will be distributed,

  • AGRIFLU® (Novartis), a trivalent vaccine that is supplied in 10-dose vials
  • FLUZONE®  (Sanofi Pasteur),a quadrivalent vaccine that is supplied in 10-dose vials
  • FLUVIRAL® (GSK, Inc.), a trivalent vaccine that is supplied in 10-dose vials\
  • FLUAD® (Novartis), an adjuvanted vaccine that is supplied in pre-filled syringes
  • FluLaval Tetra® (GSK Inc), a quadrivalent vaccine that is supplied in 10 dose vial
  • Influvac® (BGP Pharma Inc), a trivalent vaccine that is supplied in pre-filled syringes
  • Flumist® (AstraZeneca Canada), a quadrivalent live attenuated vaccine that is administered intra nasally

Except for the Flumist®, they are all split-virus, inactivated vaccines. They all contain the following antigens:

  • A/California/7/2009(H1N1)
  • A/Switzerland/9715293/2013(H3N2)
  • B/Phuket/3073/2013-like virus
  • B/Brisbane/60/2008-like virus strain (for the quadrivalent only)

[top]

Influenza vaccine contraindications and precaution

Consult the product monograph 

[top]

Report of adverse events following immunization (AEFI)

All adverse events following administration of an influenza vaccine must be reported to Ottawa Public Health within 24 hours by fax to 613-580-9660, attention to Kerry Kennedy using the AEFI form [PDF 200 KB]. If you have any questions related to the reporting of adverse events following immunization, please call 613-580-6744, ext. 23504.

[top]

Health care Agencies and workplaces excluding doctors providing influenza vaccine clinics

Immunization is the single most effective means to reduce the impact of influenza, as it can prevent or attenuate influenza illness, reduce complications such as pneumonia, hospitalizations, and mortality.

Ottawa Public Health seeks to support you in your efforts to increase vaccine coverage in your facility by offering information and resources, and by having public health staff available for consultation. For information on the 2015/2016 Seasonal UIIP, please email uiip.moh@ontario.ca.

Return unused vaccine to the Ottawa Public Health Vaccine Program once your clinics are finished for the season using Ottawa Public Health Vaccine Return Form.

[top]

More information

  • Ministry of Health and Long-Term Care (MOHLTC)
  • Ottawa Public Health Immunization contact information
    • Forms and resources
    • To order vaccine fax the Influenza vaccine order form to 613-580-2783
    • Questions regarding a vaccine order 613-580-6744, ext. 24225 or email vaccine@ottawa.ca
    • Vaccine-associated adverse events reporting form fax to 613-580-9660, questions 613-580-6744, ext. 19241
    • Hospitals, long-term care, retirement homes call the outbreak reporting line 613-580-6744 ext 26325
    • Workplaces call Ottawa Public Health Information 613-580-6744, ext. 15414
  • Manufacturers’ telephone numbers:
    • Sanofi Pasteur (Vaxigrip® and Fluzone®) 1-888-621-1146,
    • Novartis (Fluad® and Agriflu®) 1-888-363-8883
    • GlaxoSmithKline, Inc. (Fluviral®) and fluLavalTetra® 1-800-387-7374
    • BGP Pharma Inc Influvac ® 1-800-699-9948
    • AstraZeneca Canada (Flumist®) 1-800-461-3787

[top]